[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-regeneron-is-up-39-in-the-last-6-months-heres-how-much-the-stock-could-rise-in-2026-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":343},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},95608,"Regeneron est en hausse de 39% au cours des 6 derniers mois. Voici à combien pourrait s'élever l'action en 2026","2026-03-03T21:05:00","2026-03-03T17:30:06","\u003Cp>Regeneron a gagné 39 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse significative en 2026. Voici pourquoi la croissance du Dupixent, la dynamique de l'EYLEA HD et l'expansion du pipeline continuent de soutenir la configuration.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-regn-stock\">\u003Cstrong>Statistiques clés pour l'action REGN\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance sur 6 mois :\u003C\u002Fstrong> 39%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 476 $ à 821\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix cible du modèle d'évaluation :\u003C\u002Fstrong> 999\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Hausse implicite\u003C\u002Fstrong>: 26\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Évaluez vos actions préférées comme Regeneron Pharmaceuticals avec 5 ans de prévisions d'analystes en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>\u003Cstrong>Que s'est-il passé ?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=33715&tid=2642551&ref=srk6m3\">\u003Cstrong>L'action Regeneron Pharmaceuticals\u003C\u002Fstrong>\u003C\u002Fa> a progressé d'environ \u003Cstrong>39% au cours des six derniers mois\u003C\u002Fstrong>, se négociant récemment à près de \u003Cstrong> 780 dollars par action\u003C\u002Fstrong>, les investisseurs ayant réagi à l'accélération de la croissance du Dupixent, à la forte adoption de l'EYLEA HD et à l'élargissement de la visibilité du pipeline à l'horizon 2026. \u003Cbr>\u003Cbr>Les actions restent juste en dessous de leur \u003Cstrong> plus haut de 52 semaines à 821 dollars\u003C\u002Fstrong>, ce qui reflète une demande institutionnelle soutenue plutôt qu'une spéculation à court terme.\u003C\u002Fp>\n\n\n\n\u003Cp>Le rallye a pris de l'ampleur après que Regeneron ait annoncé un résultat nettement supérieur à celui du quatrième trimestre et renforcé sa confiance dans la croissance de 2026. \u003Cbr>\u003Cbr>La société a annoncé un chiffre d'affaires de 3,88 milliards de dollars contre 3,76 milliards de dollars attendus et un BPA de 11,44 dollars contre 10,74 dollars attendus, alors que les ventes mondiales de Dupixent ont bondi de 32% à 4,9 milliards de dollars, que les ventes américaines d'EYLEA HD ont bondi de 66% à 506 millions de dollars et que LIBTAYO a progressé de 13% à 425 millions de dollars. \u003Cbr>\u003Cbr>Le PDG Leonard Schleifer a déclaré que l'entreprise \"a clôturé 2025 avec un autre trimestre solide d'exécution commerciale\", et la direction a prévu des dépenses de R&D pour 2026 de 5,9 à 6,1 milliards de dollars, avec des attentes d'au moins quatre approbations de la FDA au cours de l'année prochaine, renforçant ainsi la visibilité des catalyseurs à court terme.\u003C\u002Fp>\n\n\n\n\u003Cp>L'élan réglementaire a encore renforcé l'histoire. Dupixent a reçu une extension d'étiquette de la FDA et une recommandation pédiatrique positive de l'EMA, élargissant ainsi sa population adressable dans les indications immunologiques. \u003Cbr>\u003Cbr>La société a également augmenté son dividende trimestriel à 0,94 $ par action, ce qui témoigne de la confiance dans la durabilité du flux de trésorerie disponible et de la capacité de rendement du capital à l'horizon 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>L'activité institutionnelle a soutenu la progression. Harvest Portfolios a augmenté sa participation de 8,6 % à 107 547 actions évaluées à 60,47 millions de dollars, Handelsbanken Fonder a augmenté sa position de 24,8 % à 63 049 actions évaluées à 35,45 millions de dollars, et American Century a augmenté sa participation de 3,8 % à 660 595 actions évaluées à 371,4 millions de dollars. \u003Cbr>\u003Cbr>Mitsubishi UFJ Asset Management, TD Asset Management et Banco Santander ont également augmenté leur exposition, tandis que Rafferty Asset Management a réduit sa participation de 11,7% et que le directeur Huda Zoghbi a vendu 1 638 actions à 781,33 dollars. \u003Cbr>\u003Cbr>Les investisseurs institutionnels détiennent désormais environ 83,31% de la société, ce qui souligne la conviction continue des grands détenteurs malgré la réduction sélective.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"2293\" height=\"2560\" data-public-id=\"images\u002FREGN_valuation_model-2\u002FREGN_valuation_model-2.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2293,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1772557691\u002Fimages\u002FREGN_valuation_model-2\u002FREGN_valuation_model-2.webp?_i=AA\" alt=\"Regeneron Pharmaceuticals stock\" class=\"wp-post-95608 wp-image-95615\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772557691\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Modèle d'évaluation guidée de REGN\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour Regeneron Pharmaceuticals (C'est gratuit) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-is-regn-undervalued\">REGN est-il sous-évalué ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Dans les hypothèses de valorisation, l'action est modélisée à l'aide de :\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Croissance du chiffre d'affaires (CAGR) :\u003C\u002Fstrong> 9,1%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Marges d'exploitation : \u003C\u002Fstrong>37%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Multiple P\u002FE de sortie : \u003C\u002Fstrong>15,5x\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>Le chiffre d'affaires devrait passer d'environ 14,3 milliards de dollars en 2025 à environ 21,0 milliards de dollars en 2030, principalement grâce à la pénétration continue du Dupixent dans l'asthme, la dermatite atopique, la BPCO et les nouvelles indications en immunologie. \u003Cbr>\u003Cbr>Le facteur clé est le mélange. Les revenus à forte marge de l'immunologie compensent de plus en plus la pression sur les prix de l'ophtalmologie, permettant à la croissance des bénéfices de dépasser la croissance des revenus si l'expansion des indications se poursuit.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"2560\" height=\"1706\" data-public-id=\"images\u002FTIKR.com_REGN-Regeneron-Pharmaceuticals-Inc.-Revenue-and-Revenue-Change-YoY-1\u002FTIKR.com_REGN-Regeneron-Pharmaceuticals-Inc.-Revenue-and-Revenue-Change-YoY-1.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2560,h_1706,c_scale\u002Ff_webp,q_auto\u002Fv1772557702\u002Fimages\u002FTIKR.com_REGN-Regeneron-Pharmaceuticals-Inc.-Revenue-and-Revenue-Change-YoY-1\u002FTIKR.com_REGN-Regeneron-Pharmaceuticals-Inc.-Revenue-and-Revenue-Change-YoY-1.webp?_i=AA\" alt=\"Regeneron Pharmaceuticals stock\" class=\"wp-post-95608 wp-image-95616\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772557702\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Estimations de croissance des revenus et des analystes de REGN sur cinq ans\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Les marges d'exploitation proches de \u003Cstrong>37 %\u003C\u002Fstrong> supposent un effet de levier soutenu de Dupixent et une contribution accrue des actifs oncologiques tels que LIBTAYO et d'autres programmes en phase finale de développement. \u003Cbr>\u003Cbr>La conversion continue de l'EYLEA HD et l'expansion réglementaire soutiennent la durabilité des bénéfices, tandis qu'au moins quatre approbations attendues de la FDA au cours de l'année prochaine pourraient ajouter des flux de revenus supplémentaires qui ne sont pas encore entièrement reflétés dans les multiples à venir.\u003C\u002Fp>\n\n\n\n\u003Cp>À environ \u003Cstrong> 780 dollars par action\u003C\u002Fstrong>, le cadre d'évaluation implique un prix cible de \u003Cstrong> 999 dollars\u003C\u002Fstrong>, ce qui représente une \u003Cstrong>hausse totale d'\u003C\u002Fstrong> environ \u003Cstrong>26 %\u003C\u002Fstrong> en 2026. \u003Cbr>\u003Cbr>Cela suggère que l'action reste modérément \u003Cstrong>sous-évaluée\u003C\u002Fstrong>, à condition que Dupixent maintienne une croissance à deux chiffres et que l'exécution du pipeline se poursuive.\u003C\u002Fp>\n\n\n\n\u003Cp>Les performances de cette année dépendront probablement de l'extension des étiquettes de Dupixent, des résultats en oncologie, des tendances d'adoption d'EYLEA HD et de la stabilité de la marge d'exploitation au-dessus de 35 %. \u003Cbr>\u003Cbr>Une expansion soutenue de la gamme de produits à marge élevée, combinée à des jalons réglementaires, pourrait soutenir la dynamique continue des bénéfices, positionnant Regeneron pour une nouvelle hausse si l'exécution reste cohérente.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez instantanément la juste valeur d'une société (gratuit avec TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-how-much-upside-does-regn-stock-have-from-here\">\u003Cstrong>\u003Cstrong>\u003Cstrong>Quelle est l'ampleur de la hausse de l'action REGN à partir de maintenant ?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Les investisseurs peuvent estimer le prix potentiel de l'action de Regeneron Pharmaceuticals, ou ce que toute action pourrait valoir, en moins d'une minute en utilisant le \u003Cstrong>nouveau modèle d'évaluation de TIKR\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Tout ce qu'il faut, ce sont trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>Croissance du chiffre d'affaires\u003C\u002Fli>\n\n\n\n\u003Cli>Marges d'exploitation\u003C\u002Fli>\n\n\n\n\u003Cli>Multiplicateur de prix de sortie\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de \u003Cstrong>scénarios\u003C\u002Fstrong> \u003Cstrong>haussier, baissier et de base,\u003C\u002Fstrong> ce qui vous permet de voir rapidement si une action semble \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Découvrez la valeur réelle de Regeneron Pharmaceuticals, ou de toute autre action, en moins de 60 secondes (gratuit avec TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n",725,"fr","\u002Fblog\u002Fregeneron-is-up-39-in-the-last-6-months-heres-how-much-the-stock-could-rise-in-2026","regeneron-is-up-39-in-the-last-6-months-heres-how-much-the-stock-could-rise-in-2026","images\u002F@Elnur-via-Canva-213\u002F@Elnur-via-Canva-213","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772558762\u002Fimages\u002F@Elnur-via-Canva-213\u002F@Elnur-via-Canva-213.png?_i=AA",{"altText":237,"imageCredit":238},"Regeneron Is Up 39% in the Last 6 Months. Here’s How Much the Stock Could Rise in 2026","@Elnur via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Nikko Henson","nikkotikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Regeneron is up 39% in the last six months, and our analysis suggests the stock could still deliver meaningful upside in 2026. Here’s why Dupixent growth, EYLEA HD momentum, and pipeline expansion continue to support the setup.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[266,281,296,313,328],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"Microsoft a progressé de 3 % cette semaine. Voici à combien pourrait s'élever l'action en 2026","2026-03-03 20:35:00","L'action Microsoft a augmenté d'environ 3 % cette semaine après avoir publié des résultats solides pour le deuxième trimestre 2026, et notre analyse suggère que l'action pourrait offrir une hausse significative en 2026. Voici pourquoi l'accélération de la croissance d'Azure, l'augmentation du carnet de commandes et la monétisation de l'IA continuent de soutenir la configuration.",688,"\u002Fblog\u002Fmicrosoft-rose-3-this-week-heres-how-much-the-stock-could-rise-in-2026","microsoft-rose-3-this-week-heres-how-much-the-stock-could-rise-in-2026","images\u002F@Natee-Meepians-Images-via-Canva\u002F@Natee-Meepians-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772557236\u002Fimages\u002F@Natee-Meepians-Images-via-Canva\u002F@Natee-Meepians-Images-via-Canva.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":291,"categories":293,"relatedPosts":295},"Marathon Petroleum est en hausse de 29 % depuis le début de l'année. Voici où l'action pourrait aller en 2026","2026-03-03 20:05:00","Marathon Petroleum est en hausse de 29% depuis le début de l'année, et notre analyse suggère que le titre pourrait continuer à progresser en 2026. Voici pourquoi la durabilité des marges de raffinage, les avantages du brut acide et les rendements du capital disciplinés continuent de soutenir la configuration.",822,"\u002Fblog\u002Fmarathon-petroleum-is-up-29-year-to-date-heres-where-the-stock-could-go-in-2026","marathon-petroleum-is-up-29-year-to-date-heres-where-the-stock-could-go-in-2026","images\u002F@Thossaphol-from-Getty-Images-via-Canva-1\u002F@Thossaphol-from-Getty-Images-via-Canva-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772554843\u002Fimages\u002F@Thossaphol-from-Getty-Images-via-Canva-1\u002F@Thossaphol-from-Getty-Images-via-Canva-1.png?_i=AA",{"altText":282},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":292},[],[294],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":297,"date":298,"excerpt":299,"wordCount":300,"uri":301,"slug":302,"cloudinaryAssetId":303,"featuredImageOriginalUrl":304,"featuredImageMetadata":305,"author":306,"categories":310,"relatedPosts":312},"Le chiffre d'affaires du Yeztugo de Gilead Sciences va bondir de 400 % : Voici ce qui va suivre","2026-03-03 20:00:00","Le chiffre d'affaires du Yeztugo devrait passer de 150 millions de dollars à 800 millions de dollars en une seule année, et avec l'acquisition d'Arcellx pour 7,8 milliards de dollars au deuxième trimestre, l'histoire de la croissance de Gilead ne fait que commencer.",801,"\u002Fblog\u002Fgilead-sciences-yeztugo-revenue-is-set-to-jump-400-heres-what-comes-next","gilead-sciences-yeztugo-revenue-is-set-to-jump-400-heres-what-comes-next","images\u002FFEATURED-IMAGE-MAKER-393\u002FFEATURED-IMAGE-MAKER-393","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772554449\u002Fimages\u002FFEATURED-IMAGE-MAKER-393\u002FFEATURED-IMAGE-MAKER-393.png?_i=AA",{"altText":297},{"name":307,"slug":308,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":309},"Gian Estrada","giantikr",[],[311],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":314,"date":315,"excerpt":316,"wordCount":317,"uri":318,"slug":319,"cloudinaryAssetId":320,"featuredImageOriginalUrl":321,"featuredImageMetadata":322,"author":323,"categories":325,"relatedPosts":327},"Merck a augmenté de 42% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026","2026-03-03 19:35:00","L'action Merck a progressé de 42 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse significative jusqu'en 2026. Voici pourquoi la durabilité de l'oncologie, l'élan du pipeline et le soutien institutionnel constant continuent de soutenir la configuration.",705,"\u002Fblog\u002Fmerck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","merck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","images\u002F@TrueCreatives-via-Canva-123\u002F@TrueCreatives-via-Canva-123","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772556024\u002Fimages\u002F@TrueCreatives-via-Canva-123\u002F@TrueCreatives-via-Canva-123.png?_i=AA",{"altText":314},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":324},[],[326],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":329,"date":330,"excerpt":331,"wordCount":332,"uri":333,"slug":334,"cloudinaryAssetId":335,"featuredImageOriginalUrl":336,"featuredImageMetadata":337,"author":338,"categories":340,"relatedPosts":342},"LyondellBasell est en hausse de 28 % depuis le début de l'année. Voici où les actions pourraient aller en 2026","2026-03-03 19:05:00","L'action LyondellBasell est en hausse de 28 % depuis le début de l'année en 2026, car le resserrement des stocks de polyéthylène et la forte génération de liquidités soutiennent l'idée d'un rebond. Voici pourquoi le redressement des marges et la discipline en matière d'approvisionnement pourraient encore entraîner une hausse significative par rapport aux niveaux actuels.",790,"\u002Fblog\u002Flyondellbasell-is-up-28-year-to-date-heres-where-shares-could-go-in-2026","lyondellbasell-is-up-28-year-to-date-heres-where-shares-could-go-in-2026","images\u002F@Stas_V-from-Getty-Images-via-Canva-213\u002F@Stas_V-from-Getty-Images-via-Canva-213","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772552857\u002Fimages\u002F@Stas_V-from-Getty-Images-via-Canva-213\u002F@Stas_V-from-Getty-Images-via-Canva-213.png?_i=AA",{"altText":329},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":339},[],[341],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[344,364,379,394,411,426,444,458,473,487],{"id":255,"title":345,"date":346,"excerpt":347,"wordCount":348,"uri":349,"slug":350,"cloudinaryAssetId":351,"featuredImageOriginalUrl":352,"featuredImageMetadata":353,"author":354,"categories":358,"relatedPosts":363},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":345},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":357},"Aditya Raghunath","adityatikr",[],[359],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":365,"date":366,"excerpt":367,"wordCount":368,"uri":369,"slug":370,"cloudinaryAssetId":371,"featuredImageOriginalUrl":372,"featuredImageMetadata":373,"author":374,"categories":376,"relatedPosts":378},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":365},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":375},[],[377],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":380,"date":381,"excerpt":382,"wordCount":383,"uri":384,"slug":385,"cloudinaryAssetId":386,"featuredImageOriginalUrl":387,"featuredImageMetadata":388,"author":389,"categories":391,"relatedPosts":393},"Le financement massif d'OpenAI déclenche la chute des actions d'Amazon","2026-03-02 10:30:00","L'action d'Amazon a chuté après la levée de fonds de 110 milliards de dollars d'OpenAI, malgré l'engagement d'Amazon à hauteur de 50 milliards de dollars et la conclusion d'un accord de partenariat majeur avec AWS.",831,"\u002Fblog\u002Fopenai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","openai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","images\u002FAMZN-stock-1\u002FAMZN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772278707\u002Fimages\u002FAMZN-stock-1\u002FAMZN-stock-1.png?_i=AA",{"altText":380},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":390},[],[392],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":395,"date":396,"excerpt":397,"wordCount":398,"uri":399,"slug":400,"cloudinaryAssetId":401,"featuredImageOriginalUrl":402,"featuredImageMetadata":403,"author":404,"categories":408,"relatedPosts":410},"L'action Chime bondit de 14 % sur la voie de la rentabilité selon les GAAP : voici où l'action pourrait se diriger en 2026","2026-03-01 15:00:00","Les actions de Chime Financial (CHYM) sont en train d'enregistrer une forte hausse après la publication de leurs résultats, suite à la publication d'un rapport sur le quatrième trimestre qui a fait date.",743,"\u002Fblog\u002Fchime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","chime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","images\u002F21-2\u002F21-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322176\u002Fimages\u002F21-2\u002F21-2.png?_i=AA",{"altText":395},{"name":405,"slug":406,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":407},"Wiltone Asuncion","wiltonetikr",[],[409],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":412,"date":413,"excerpt":414,"wordCount":415,"uri":416,"slug":417,"cloudinaryAssetId":418,"featuredImageOriginalUrl":419,"featuredImageMetadata":420,"author":421,"categories":423,"relatedPosts":425},"L'action de Crescent Energy bondit de 7 % grâce à des synergies doublées dans le Permien : Voici où l'action pourrait aller en 2026","2026-03-01 14:50:00","Crescent Energy Company (CRGY) aborde l'année 2026 en tant qu'opérateur multi-bassins à grande échelle, après avoir réalisé des transactions d'une valeur de près de 5 milliards de dollars. ",816,"\u002Fblog\u002Fcrescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","crescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","images\u002F20-2\u002F20-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322164\u002Fimages\u002F20-2\u002F20-2.png?_i=AA",{"altText":412},{"name":405,"slug":406,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":422},[],[424],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":427,"date":428,"excerpt":429,"wordCount":430,"uri":431,"slug":432,"cloudinaryAssetId":433,"featuredImageOriginalUrl":434,"featuredImageMetadata":435,"author":436,"categories":438,"relatedPosts":443},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":427},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":437},[],[439],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":445,"date":366,"excerpt":446,"wordCount":447,"uri":448,"slug":449,"cloudinaryAssetId":450,"featuredImageOriginalUrl":451,"featuredImageMetadata":452,"author":453,"categories":455,"relatedPosts":457},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27% à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":445},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":454},[],[456],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":459,"date":460,"excerpt":461,"wordCount":462,"uri":463,"slug":464,"cloudinaryAssetId":465,"featuredImageOriginalUrl":466,"featuredImageMetadata":467,"author":468,"categories":470,"relatedPosts":472},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":459},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":469},[],[471],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":474,"date":460,"excerpt":475,"wordCount":476,"uri":477,"slug":478,"cloudinaryAssetId":479,"featuredImageOriginalUrl":480,"featuredImageMetadata":481,"author":482,"categories":484,"relatedPosts":486},"En hausse de 19 % au cours des 12 derniers mois, les valeurs financières régionales peuvent-elles encore progresser en 2026 ?","Des bénéfices solides au quatrième trimestre et un taux de rendement des capitaux propres de 18 % placent Regions Financial en position de croissance. Notre modèle prévoit une hausse de 26 % pour atteindre 35 $ d'ici 2028. L'action RF peut-elle tenir ses promesses en 2026 ?",1264,"\u002Fblog\u002Fup-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","up-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","images\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772446487\u002Fimages\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63.png?_i=AA",{"altText":474},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":483},[],[485],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":488,"date":489,"excerpt":490,"wordCount":491,"uri":492,"slug":493,"cloudinaryAssetId":494,"featuredImageOriginalUrl":495,"featuredImageMetadata":496,"author":497,"categories":499,"relatedPosts":501},"En baisse de 65 % par rapport à son plus haut niveau historique, l'action Brown-Forman peut-elle offrir de meilleurs résultats en 2026 ?","2026-03-03 09:45:00","L'action Brown-Forman pourrait atteindre 36 dollars d'ici 2028 grâce au succès du Blackberry de Jack Daniel et à la croissance des marchés émergents, malgré des vents contraires à court terme dans le secteur de la consommation.",1334,"\u002Fblog\u002Fdown-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","down-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","images\u002FBFB-stock\u002FBFB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772433508\u002Fimages\u002FBFB-stock\u002FBFB-stock.png?_i=AA",{"altText":488},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":498},[],[500],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[]]